BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 9160265)

  • 1. Mangafodipir trisodium injection, a new contrast medium for magnetic resonance imaging: in vitro metabolism and protein binding studies of the active component MnDPDP in human blood.
    Toft KG; Kindberg GM; Skotland T
    J Pharm Biomed Anal; 1997 Apr; 15(7):983-8. PubMed ID: 9160265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mangafodipir trisodium injection, a new contrast medium for magnetic resonance imaging: detection and quantitation of the parent compound MnDPDP and metabolites in human plasma by high performance liquid chromatography.
    Toft KG; Friisk GA; Skotland T
    J Pharm Biomed Anal; 1997 Apr; 15(7):973-81. PubMed ID: 9160264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolism and pharmacokinetics of MnDPDP in man.
    Toft KG; Hustvedt SO; Grant D; Martinsen I; Gordon PB; Friisk GA; Korsmo AJ; Skotland T
    Acta Radiol; 1997 Jul; 38(4 Pt 2):677-89. PubMed ID: 9245963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolism of mangafodipir trisodium (MnDPDP), a new contrast medium for magnetic resonance imaging, in beagle dogs.
    Toft KG; Hustvedt SO; Grant D; Friisk GA; Skotland T
    Eur J Drug Metab Pharmacokinet; 1997; 22(1):65-72. PubMed ID: 9179562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dephosphorylation of MnDPDP and related compounds by acid and alkaline phosphatase.
    Toft KG; Myrset AH; Skotland T
    J Pharm Biomed Anal; 2001 Jun; 25(3-4):613-8. PubMed ID: 11377042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stability and transmetallation of the magnetic resonance contrast agent MnDPDP measured by EPR.
    Schmidt PP; Toft KG; Skotland T; Andersson K
    J Biol Inorg Chem; 2002 Mar; 7(3):241-8. PubMed ID: 11935348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of manganese dipyridoxyl diphosphate, dipyridoxyl diphosphate--, and manganese chloride on cardiac function. An experimental study in the Langendorff perfused rat heart.
    Brurok H; Schjøtt J; Berg K; Karlsson JO; Jynge P
    Invest Radiol; 1995 Mar; 30(3):159-67. PubMed ID: 7797414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of MnDPDP, DPDP--, and MnCl2 on cardiac energy metabolism and manganese accumulation. An experimental study in the isolated perfused rat heart.
    Brurok H; Schjøtt J; Berg K; Karlsson JO; Jynge P
    Invest Radiol; 1997 Apr; 32(4):205-11. PubMed ID: 9101355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calmangafodipir [Ca4Mn(DPDP)5], mangafodipir (MnDPDP) and MnPLED with special reference to their SOD mimetic and therapeutic properties.
    Karlsson JO; Ignarro LJ; Lundström I; Jynge P; Almén T
    Drug Discov Today; 2015 Apr; 20(4):411-21. PubMed ID: 25463039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physicochemical characterisation of mangafodipir trisodium.
    Tirkkonen B; Aukrust A; Couture E; Grace D; Haile Y; Holm KM; Hope H; Larsen A; Lunde HS; Sjøgren CE
    Acta Radiol; 1997 Jul; 38(4 Pt 2):780-9. PubMed ID: 9245974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma pharmacokinetics, tissue distribution and excretion of MnDPDP in the rat and dog after intravenous administration.
    Hustvedt SO; Grant D; Southon TE; Zech K
    Acta Radiol; 1997 Jul; 38(4 Pt 2):690-9. PubMed ID: 9245964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mangafodipir trisodium (MnDPDP)-enhanced magnetic resonance imaging of the liver and pancreas.
    Wang C
    Acta Radiol Suppl; 1998; 415():1-31. PubMed ID: 9571956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of manganese biodistribution and MR contrast enhancement in rats after intravenous injection of MnDPDP and MnCl2.
    Ni Y; Petré C; Bosmans H; Miao Y; Grant D; Baert AL; Marchal G
    Acta Radiol; 1997 Jul; 38(4 Pt 2):700-7. PubMed ID: 9245965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MnDPDP: Contrast Agent for Imaging and Protection of Viable Tissue.
    Jynge P; Skjold AM; Falkmer U; Andersson RGG; Seland JG; Bruvold M; Blomlie V; Eidsaunet W; Karlsson JOG
    Contrast Media Mol Imaging; 2020; 2020():3262835. PubMed ID: 32994754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myocardial manganese elevation and proton relaxivity enhancement with manganese dipyridoxyl diphosphate. Ex vivo assessments in normally perfused and ischemic guinea pig hearts.
    Brurok H; Skoglund T; Berg K; Skarra S; Karlsson JO; Jynge P
    NMR Biomed; 1999 Oct; 12(6):364-72. PubMed ID: 10516618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac metal contents after infusions of manganese. An experimental evaluation in the isolated rat heart.
    Brurok H; Berg K; Sneen L; Grant D; Karlsson JO; Jynge P
    Invest Radiol; 1999 Jul; 34(7):470-6. PubMed ID: 10399637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NMR relaxation studies with MnDPDP.
    Southon TE; Grant D; Bjørnerud A; Moen OM; Spilling B; Martinsen I; Refsum H
    Acta Radiol; 1997 Jul; 38(4 Pt 2):708-16. PubMed ID: 9245966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spectroscopic and metabolic effects of MnCl2 and MnDPDP on the isolated and perfused rat heart.
    Vander Elst L; Colet JM; Muller RN
    Invest Radiol; 1997 Oct; 32(10):581-8. PubMed ID: 9342116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mangafodipir as a cardioprotective adjunct to reperfusion therapy: a feasibility study in patients with ST-segment elevation myocardial infarction.
    Karlsson JE; El-Saadi W; Ali M; Puskar W; Skogvard P; Engvall JE; Andersson RG; Maret E; Jynge P
    Eur Heart J Cardiovasc Pharmacother; 2015 Jan; 1(1):39-45. PubMed ID: 27533964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mangafodipir trisodium injection (Mn-DPDP). A contrast agent for abdominal MR imaging.
    Rofsky NM; Earls JP
    Magn Reson Imaging Clin N Am; 1996 Feb; 4(1):73-85. PubMed ID: 8673718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.